DOW JONES22,117.96+481.18 2.22%
S&P 5002,606.99+65.52 2.58%
NASDAQ7,726.11+223.73 2.98%

Baird Maintains Outperform on Homology Medicines, Raises Price Target to $32

Baird maintains Homology Medicines (NASDAQ:FIXX) with a Outperform and raises the price target from $30 to $32.

Benzinga · 03/13/2020 14:21

Baird maintains Homology Medicines (NASDAQ:FIXX) with a Outperform and raises the price target from $30 to $32.